These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19692100)

  • 21. What is driving the HIV epidemic in French Guiana?
    Nacher M; Vantilcke V; Parriault MC; Van Melle A; Hanf M; Labadie G; Romeo M; Adriouch L; Carles G; Couppié P
    Int J STD AIDS; 2010 May; 21(5):359-61. PubMed ID: 20498108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complications and side effects. France: a large hospital database looks at heart attacks.
    TreatmentUpdate; 2009; 21(3):9-11. PubMed ID: 19623730
    [No Abstract]   [Full Text] [Related]  

  • 23. Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitution.
    Murdaca G; Contini P; Setti M; Cagnati P; Lantieri F; Indiveri F; Puppo F
    Clin Immunol; 2009 Nov; 133(2):238-44. PubMed ID: 19762282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity and lymphocyte subsets in virologically suppressed HIV-infected patients.
    Adeyemi OM; Vibhakar S; Evans AT
    Metabolism; 2009 Sep; 58(9):1285-7. PubMed ID: 19497596
    [No Abstract]   [Full Text] [Related]  

  • 25. Adherence to HAART: Africans take medicines more faithfully than North Americans.
    Attaran A
    PLoS Med; 2007 Feb; 4(2):e83. PubMed ID: 17326715
    [No Abstract]   [Full Text] [Related]  

  • 26. Factors influencing the natural history of HIV-1 infection.
    Qu W; Robinson M; Zhang FJ
    Chin Med J (Engl); 2008 Dec; 121(24):2613-21. PubMed ID: 19187605
    [No Abstract]   [Full Text] [Related]  

  • 27. [How HIV treatment can be simplified. "Once daily" as starter therapy is effective].
    Wepner U
    MMW Fortschr Med; 2009 Apr; 151(18):80-1. PubMed ID: 19769085
    [No Abstract]   [Full Text] [Related]  

  • 28. Pneumocystis-associated organizing pneumonia as a manifestation of immune reconstitution inflammatory syndrome in an HIV-infected individual with a normal CD4+ T-cell count following antiretroviral therapy.
    Mori S; Polatino S; Estrada-Y-Martin RM
    Int J STD AIDS; 2009 Sep; 20(9):662-5. PubMed ID: 19710347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-infections. Reducing risk form severe liver injury.
    TreatmentUpdate; 2006; 18(1):3-4. PubMed ID: 17228458
    [No Abstract]   [Full Text] [Related]  

  • 30. Anti-HIV agents. When is it best to start HAART?
    TreatmentUpdate; 2009; 21(3):2. PubMed ID: 19623724
    [No Abstract]   [Full Text] [Related]  

  • 31. Borderline tuberculoid leprosy with upgrading Type 1 reaction in a HIV seropositive patient, after antiretroviral therapy: an immune reconstitution inflammatory syndrome.
    Kar HK; Sharma P; Bhardwaj M
    Lepr Rev; 2009 Mar; 80(1):85-8. PubMed ID: 19472856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-HAART tuberculosis in adults and adolescents with HIV in India: incidence, clinical and immunological profile.
    Rajasekaran S; Raja K; Jeyaseelan L; Vijilat S; Priya K; Mohan K; Parvez A; Mahilmaran A; Chandrasekar C
    Indian J Tuberc; 2009 Apr; 56(2):69-76. PubMed ID: 19810588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes in a hospital cohort of persons living with HIV: a descriptive and comparative study in French Guiana.
    Nacher M; Rabier S; Lucarelli A; Hureau L; Adenis A; Hafsi N; Sabbah N
    BMC Infect Dis; 2023 Jul; 23(1):470. PubMed ID: 37442942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A role for ageing and HIV infection in HIV-related cancer risk.
    Vajdic CM; van Leeuwen MT; Grulich AE
    AIDS; 2009 Jun; 23(9):1183-4. PubMed ID: 19451797
    [No Abstract]   [Full Text] [Related]  

  • 35. Side effects and complications. French study clears HAART of cancer link in kids.
    TreatmentUpdate; 2009 Feb; 21(2):7-8. PubMed ID: 19391264
    [No Abstract]   [Full Text] [Related]  

  • 36. Is HAART modifying the HIV epidemic?
    Maggiolo F; Leone S
    Lancet; 2010 Aug; 376(9740):492-3. PubMed ID: 20638714
    [No Abstract]   [Full Text] [Related]  

  • 37. Safety and efficacy of CKBM-A01, a Chinese herbal medicine, among asymptomatic HIV patients.
    Maek-a-nantawat W; Phonrat B; Dhitavat J; Naksrisook S; Muanaum R; Ngamdee V; Pitisuttithum P
    Southeast Asian J Trop Med Public Health; 2009 May; 40(3):494-501. PubMed ID: 19842434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of a hospital stay high after starting HAART.
    Proj Inf Perspect; 2008 Dec; (47):16-7. PubMed ID: 19227567
    [No Abstract]   [Full Text] [Related]  

  • 39. Responding to the HIV epidemic in the developing world. Capacity building and technology transfer for monitoring with HAART: a Caribbean experience.
    Abayomi A; Adomakoh N; Adomakoh S
    Afr J Med Med Sci; 2006 Dec; 35 Suppl():19-24. PubMed ID: 18050773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Scientific round table--highlights of the 16th CROI 2009. Focus on current therapy studies].
    Sankawa Y
    MMW Fortschr Med; 2009 Apr; 151(18):34-5. PubMed ID: 19769071
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.